2024 American Society of Clinical Oncology (ASCO)

 

 

Review presentations, oral abstracts, and other information shared by Dana-Farber physician-scientists at the ASCO 2024 Annual Meeting.

 

Prostate Cancer Highlights presented by Michael Serzan, MD Video

Prostate Cancer Highlights presented by Michael Serzan, MD

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from ASCO 2024.
Michael Serzan, MD

Michael Serzan, MD

Medical Oncologist
Kidney Cancer Highlights presented by Michael Serzan, MD Video

Kidney Cancer Highlights presented by Michael Serzan, MD

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates you need to know from ASCO 2024.
Michael Serzan, MD

Michael Serzan, MD

Medical Oncologist
Bladder Cancer Highlights presented by Michael Serzan, MD Video

Bladder Cancer Highlights presented by Michael Serzan, MD

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from ASCO 2024.
Michael Serzan, MD

Michael Serzan, MD

Medical Oncologist
Narjust Florez, MD Discusses International Medical Graduate Challenges Video

Narjust Florez, MD Discusses International Medical Graduate Challenges

1 out of 4 doctors in the United States graduated from international medical schools, yet according to a study presented at ASCO24, these doctors remain victims of discrimination at frequent rates.
Narjust Florez, MD

Narjust Florez, MD

Medical Oncology
Jia Luo, MD Discusses NUT Carcinoma Video

Jia Luo, MD Discusses NUT Carcinoma

NUT Carcinoma may not be as rare as one thought. Jia Luo, MD, of Dana-Farber, shares new efforts to research this type of rare cancer that can grow anywhere in the body, often in the head, neck and lungs.
Jia Luo, MD

Jia Luo, MD

Medical Oncology
Kimia Sorouri, MD, MPH Discusses Fertility and Breast Cancer Video

Kimia Sorouri, MD, MPH Discusses Fertility and Breast Cancer

Study shows most women attempting to conceive after breast cancer treatment can do so and give birth. Dana-Farber's Kimia Sorouri, MD, MPH, discusses the first prospective study with more than 10 years of follow-up that also accounts for conception attempts.
Narjust Florez, MD Discusses Young Lung Cancer Video

Narjust Florez, MD Discusses Young Lung Cancer

Lung cancer rates in younger adults are rising. Dana-Farber's Narjust Florez, MD discusses research showing that young patients with lung cancer face ample financial toxicity and issues impacting physical, emotional, and functional well-being.
Narjust Florez, MD

Narjust Florez, MD

Medical Oncology
Richard Leiter, MD, MA Featured in ASCO Voices Video

Richard Leiter, MD, MA Featured in ASCO Voices

Palliative care physician Richard Leiter, MD, MA, recounts his support of a young patient with end-of-life care and the complexities of communicating with his family.
Richard Leiter, MD, MA

Richard Leiter, MD, MA

Andrew Hantel, MD Reviews Cancer Care and Greenhouse Gases Video

Andrew Hantel, MD Reviews Cancer Care and Greenhouse Gases

Telehealth can significantly reduce greenhouse gas emissions from cancer care, with research showing decentralized cancer care and telemedicine can cut emissions 33% compared to traditional in-person visits.
Andrew Hantel, MD

Andrew Hantel, MD

Medical Oncology
Ana Garrido-Castro, MD Discusses SACI-IO HR+ Video

Ana Garrido-Castro, MD Discusses SACI-IO HR+

Antibody-drug conjugate plus a checkpoint inhibitor shows a trend toward improved survival in PD-L1-positive hormone receptor-positive, HER2-negative breast cancer.
Ana C. Garrido-Castro, MD

Ana C. Garrido-Castro, MD

Medical Oncology
Toni Choueiri, MD Discusses Kidney Cancer JAVELIN 101 Video

Toni Choueiri, MD Discusses Kidney Cancer JAVELIN 101

Kidney cancer research at ASCO24: Final analysis in JAVELIN Renal 101 trial confirms the efficacy and manageable safety profile of avelumab plus axitinib versus sunitinib in patients with advanced kidney cancer. Dana-Farber's Toni Choueiri, MD, explains more.
Toni Choueiri, MD

Toni Choueiri, MD

Medical Oncology
Kenneth Kehl, MD, MPH Reviews Artificial Intelligence and Genomic Data Video

Kenneth Kehl, MD, MPH Reviews Artificial Intelligence and Genomic Data

Using artificial intelligence to link genomic data to clinical outcomes in cancer care across institutions without compromising protected health information is challenging.
Kenneth L. Kehl, MD, MPH

Kenneth L. Kehl, MD, MPH

Lakshmi Nayak, MD Discusses CNS Lymphoma Video

Lakshmi Nayak, MD Discusses CNS Lymphoma

CNS Lymphoma research at ASCO24: Dana-Farber's Lakshmi Nayak, MD, details findings of a pilot study showing a CAR T-cell therapy has shown promise and is safe and well-tolerated in treating patients with relapsed, treatment-resistant CNS lymphoma.
Lakshmi Nayak, MD

Lakshmi Nayak, MD

Neuro-oncology
Toni Choueiri, MD Provides Kidney Cancer CLEAR Trial biomarker analysis Video

Toni Choueiri, MD Provides Kidney Cancer CLEAR Trial biomarker analysis

Biomarker analysis in the phase 3 CLEAR trial shows biomarkers don't impact the superiority of lenvatinib plus pembrolizumab versus sunitinib as a first-line therapy in patients diagnosed with advanced kidney cancer.
Toni Choueiri, MD

Toni Choueiri, MD

Medical Oncology

 

News Releases

 

Resources 
 
Awards & Honors
  • Janet L. Abrahm receives ASCO Special Award: (published March 27, 2024)
  • Margaret A. Shipp, MD received OncLive's Giants in Cancer Care Award
      • The Giants of Cancer Care program aims to honor and celebrate the accomplishments of leading researchers and educators whose discoveries have propelled the field and set the groundwork for future advancements. A selection committee of more than 115 esteemed oncologists choose honorees from a range of tumor types and specialized categories. The inductees have been selected by their peers for their remarkable achievements in oncology research and clinical practice.
        • 2024 Fellow of the American Society of Clinical Oncology
            • Narjust Florez, MD
            • Shail Maingi, MD
 
Dana-Farber presence at ASCO 2024
        • Conducted nearly 30 oral abstract or clinical science symposium presentations
        • Presented more than 55 poster presentations
        • Participated in dozens of additional presentations in education sessions, special sessions or panel sessions